+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Therapeutic Vaccines Market 2019-2023 - Product Image

Global Therapeutic Vaccines Market 2019-2023

  • ID: 4774800
  • Report
  • May 2019
  • Region: Global
  • 123 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Aimmune Therapeutics Inc.
  • Novartis AG
  • Sanpower Group Co. Ltd.
  • MORE
The market is driven by the growing incidence of malignant and chronic diseases such as HIV, human papillomavirus, cancer, among others. Cancer is one of the malignant diseases that is claiming several lives across countries such as the US, the UK, and Denmark over the past few years. The prevalence of chronic diseases such as Alzheimer’s, asthma, diabetes, and multiple sclerosis are also increasing across the world. Such an increasing outspread of morbid ailments are increasing the demand for therapeutic vaccines. This is expected to drive the growth of the market at a CAGR of more than 19% during the forecast period.

Market Overview

Strong therapeutic pipeline

Key vendors in the therapeutics vaccines market are developing vaccines to resist the outbreak of several infectious and chronic diseases. Several drugs are in the late stage of clinical trials and are expected to receive marketing approval during the forecast period. For instance, Inovio Pharmaceuticals developed VGX-3100 to treat precancers in the cervix. The vaccine is currently in Phase III stage of clinical trials.

Availability of alternative therapies to treat diseases

The cost and time associated with developing a therapeutic vaccine is paving the way for the emergence of alternative treatments such as chemotherapy, and targeted therapies are widely used to treat various cancer types. Also, the availability of several US FDA approved drugs such as PROVENGE for the treatment of prostate cancer in men are hindering the growth of the market.

Competitive Landscape

The market appears to be concentrated with few players occupying the market share.

Companies such as Aimmune Therapeutics Inc. and Immune Response BioPharma Inc. have intensified the competition. Factors such as the rising incidence and prevalence of diseases and strong therapeutic vaccine pipeline will provide significant growth opportunities for therapeutic vaccine companies. Aimmune Therapeutics Inc., Immune Response BioPharma Inc., Inovio Pharmaceuticals Inc., Novartis AG, and Sanpower Group Co. Ltd. are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aimmune Therapeutics Inc.
  • Novartis AG
  • Sanpower Group Co. Ltd.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY TYPE
  • Market segmentation by type
  • Comparison by type
  • Cancer vaccines - Market size and forecast 2018-2023
  • Infectious diseases vaccines - Market size and forecast 2018-2023
  • Other diseases vaccines - Market size and forecast 2018-2023
  • Neurological diseases vaccines - Market size and forecast 2018-2023
  • Autoimmune diseases vaccines - Market size and forecast 2018-2023
  • Market opportunity by type
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Market trends
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Aimmune Therapeutics, Inc.
  • Immune Response BioPharma Inc.
  • Inovio Pharmaceuticals Inc.
  • Novartis AG
  • Sanpower Group Co. Ltd.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits:
Exhibit 01: Global vaccine market
Exhibit 02: Segments of global vaccine market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Type - Market share 2018-2023 (%)
Exhibit 18: Comparison by type
Exhibit 19: Cancer vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Cancer vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 21: Infectious diseases vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Infectious diseases vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 23: Vaccines under development for infectious diseases
Exhibit 24: Other diseases vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Other diseases vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 26: Vaccines under development for other diseases
Exhibit 27: Neurological diseases vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Neurological diseases vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 29: Vaccines under development for neurological diseases
Exhibit 30: Autoimmune diseases vaccines - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Autoimmune diseases vaccines - Year-over-year growth 2019-2023 (%)
Exhibit 32: Vaccines under development for autoimmune diseases
Exhibit 33: Market opportunity by type
Exhibit 34: Customer landscape
Exhibit 35: Market share by geography 2018-2023 (%)
Exhibit 36: Geographic comparison
Exhibit 37: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: North America - Year-over-year growth 2019-2023 (%)
Exhibit 39: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 41: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 42: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 43: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 44: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 45: Key leading countries
Exhibit 46: Market opportunity
Exhibit 47: Vaccines under development
Exhibit 48: Impact of drivers and challenges
Exhibit 49: Vendor landscape
Exhibit 50: Landscape disruption
Exhibit 51: Vendors covered
Exhibit 52: Vendor classification
Exhibit 53: Market positioning of vendors
Exhibit 54: Aimmune Therapeutics Inc. - Vendor overview
Exhibit 55: Aimmune Therapeutics Inc. - Business segments
Exhibit 56: Aimmune Therapeutics Inc. - Organizational developments
Exhibit 57: Aimmune Therapeutics Inc. - Key offerings
Exhibit 58: Immune Response BioPharma Inc. - Vendor overview
Exhibit 59: Immune Response BioPharma Inc. - Key offerings
Exhibit 60: Inovio Pharmaceuticals Inc. - Vendor overview
Exhibit 61: Inovio Pharmaceuticals Inc. - Product segments
Exhibit 62: Inovio Pharmaceuticals Inc. - Organizational developments
Exhibit 63: Inovio Pharmaceuticals Inc. - Key offerings
Exhibit 64: Novartis AG - Vendor overview
Exhibit 65: Novartis AG - Business segments
Exhibit 66: Novartis AG - Organizational developments
Exhibit 67: Novartis AG - Geographic focus
Exhibit 68: Novartis AG - Segment focus
Exhibit 69: Novartis AG - Key offerings
Exhibit 70: Sanpower Group Co. Ltd. - Vendor overview
Exhibit 71: Sanpower Group Co. Ltd. - Key offerings
Exhibit 72: Validation techniques employed for market sizing
Exhibit 73: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Aimmune Therapeutics Inc.
  • Novartis AG
  • Sanpower Group Co. Ltd.
  • MORE
The following companies are recognised as the key players in the global therapeutic market: Aimmune Therapeutics Inc., Immune Response BioPharma Inc., Inovio Pharmaceuticals Inc., Novartis AG, and Sanpower Group Co. Ltd.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the rising number of strategic alliances among vendors.”

According to the report, one of the major drivers for this market is the rising incidence and prevalence of diseases.

Further, the report states that one of the major factors hindering the growth of this market is the availability of alternative therapies to treat diseases.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Aimmune Therapeutics Inc.
  • Immune Response BioPharma Inc.
  • Inovio Pharmaceuticals Inc.
  • Novartis AG
  • Sanpower Group Co. Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll